000 | 01945 a2200565 4500 | ||
---|---|---|---|
005 | 20250515223702.0 | ||
264 | 0 | _c20100817 | |
008 | 201008s 0 0 eng d | ||
022 | _a1600-0609 | ||
024 | 7 |
_a10.1111/j.1600-0609.2010.01467.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYoon, Dok Hyun | |
245 | 0 | 0 |
_aKi-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP. _h[electronic resource] |
260 |
_bEuropean journal of haematology _cAug 2010 |
||
300 |
_a149-57 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKi-67 Antigen _xanalysis |
650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdiagnosis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aChoi, Dae Ro | |
700 | 1 | _aAhn, Heui June | |
700 | 1 | _aKim, Shin | |
700 | 1 | _aLee, Dae Ho | |
700 | 1 | _aKim, Sang-We | |
700 | 1 | _aPark, Bong-Hee | |
700 | 1 | _aYoon, Sun Och | |
700 | 1 | _aHuh, Jooryung | |
700 | 1 | _aLee, Sang-Wook | |
700 | 1 | _aSuh, Cheolwon | |
773 | 0 |
_tEuropean journal of haematology _gvol. 85 _gno. 2 _gp. 149-57 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0609.2010.01467.x _zAvailable from publisher's website |
999 |
_c19831937 _d19831937 |